Logo image of ALBIZ.PA

OBIZ SA (ALBIZ.PA) Stock Fundamental Analysis

EPA:ALBIZ - Euronext Paris - Matif - FR0014003711 - Common Stock - Currency: EUR

3.84  -0.03 (-0.78%)

Fundamental Rating

3

Overall ALBIZ gets a fundamental rating of 3 out of 10. We evaluated ALBIZ against 63 industry peers in the Media industry. ALBIZ may be in some trouble as it scores bad on both profitability and health. ALBIZ is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALBIZ had negative earnings in the past year.
ALBIZ had a positive operating cash flow in the past year.
Of the past 5 years ALBIZ 4 years were profitable.
ALBIZ had a positive operating cash flow in 4 of the past 5 years.
ALBIZ.PA Yearly Net Income VS EBIT VS OCF VS FCFALBIZ.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 1M -1M 2M -2M

1.2 Ratios

ALBIZ has a worse Return On Assets (-0.74%) than 76.19% of its industry peers.
ALBIZ has a Return On Equity of -2.82%. This is in the lower half of the industry: ALBIZ underperforms 73.02% of its industry peers.
With a Return On Invested Capital value of 1.97%, ALBIZ is not doing good in the industry: 69.84% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.74%
ROE -2.82%
ROIC 1.97%
ROA(3y)-1.38%
ROA(5y)-0.07%
ROE(3y)-2.28%
ROE(5y)3.62%
ROIC(3y)N/A
ROIC(5y)N/A
ALBIZ.PA Yearly ROA, ROE, ROICALBIZ.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 5 -5 10 15

1.3 Margins

In the last couple of years the Profit Margin of ALBIZ has declined.
The Operating Margin of ALBIZ (0.87%) is worse than 69.84% of its industry peers.
ALBIZ's Operating Margin has declined in the last couple of years.
ALBIZ has a worse Gross Margin (13.29%) than 85.71% of its industry peers.
In the last couple of years the Gross Margin of ALBIZ has declined.
Industry RankSector Rank
OM 0.87%
PM (TTM) N/A
GM 13.29%
OM growth 3Y-11.82%
OM growth 5YN/A
PM growth 3Y-46.22%
PM growth 5YN/A
GM growth 3Y-13.91%
GM growth 5YN/A
ALBIZ.PA Yearly Profit, Operating, Gross MarginsALBIZ.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 10 20 30

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALBIZ is destroying value.
The number of shares outstanding for ALBIZ has been increased compared to 1 year ago.
ALBIZ has a worse debt/assets ratio than last year.
ALBIZ.PA Yearly Shares OutstandingALBIZ.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
ALBIZ.PA Yearly Total Debt VS Total AssetsALBIZ.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

ALBIZ has an Altman-Z score of 2.96. This is not the best score and indicates that ALBIZ is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.96, ALBIZ belongs to the top of the industry, outperforming 92.06% of the companies in the same industry.
A Debt/Equity ratio of 1.70 is on the high side and indicates that ALBIZ has dependencies on debt financing.
ALBIZ has a Debt to Equity ratio of 1.70. This is in the lower half of the industry: ALBIZ underperforms 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF N/A
Altman-Z 2.96
ROIC/WACC0.31
WACC6.43%
ALBIZ.PA Yearly LT Debt VS Equity VS FCFALBIZ.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

ALBIZ has a Current Ratio of 1.87. This is a normal value and indicates that ALBIZ is financially healthy and should not expect problems in meeting its short term obligations.
ALBIZ's Current ratio of 1.87 is amongst the best of the industry. ALBIZ outperforms 87.30% of its industry peers.
A Quick Ratio of 1.33 indicates that ALBIZ should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.33, ALBIZ is in the better half of the industry, outperforming 79.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.33
ALBIZ.PA Yearly Current Assets VS Current LiabilitesALBIZ.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

7

3. Growth

3.1 Past

The earnings per share for ALBIZ have decreased strongly by -580.50% in the last year.
The earnings per share for ALBIZ have been decreasing by -20.63% on average. This is quite bad
Looking at the last year, ALBIZ shows a very strong growth in Revenue. The Revenue has grown by 185.23%.
The Revenue has been growing by 75.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-580.5%
EPS 3Y-20.63%
EPS 5YN/A
EPS Q2Q%-3100%
Revenue 1Y (TTM)185.23%
Revenue growth 3Y75.48%
Revenue growth 5YN/A
Sales Q2Q%204.93%

3.2 Future

ALBIZ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 48.88% yearly.
The Revenue is expected to grow by 14.63% on average over the next years. This is quite good.
EPS Next Y-78.57%
EPS Next 2Y47.84%
EPS Next 3Y48.88%
EPS Next 5YN/A
Revenue Next Year53.01%
Revenue Next 2Y28.59%
Revenue Next 3Y20.8%
Revenue Next 5Y14.63%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALBIZ.PA Yearly Revenue VS EstimatesALBIZ.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
ALBIZ.PA Yearly EPS VS EstimatesALBIZ.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.1 0.2 0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALBIZ. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 14.62 indicates a correct valuation of ALBIZ.
ALBIZ's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.19. ALBIZ is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 14.62
ALBIZ.PA Price Earnings VS Forward Price EarningsALBIZ.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

69.84% of the companies in the same industry are cheaper than ALBIZ, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.82
ALBIZ.PA Per share dataALBIZ.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

A more expensive valuation may be justified as ALBIZ's earnings are expected to grow with 48.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.84%
EPS Next 3Y48.88%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALBIZ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OBIZ SA

EPA:ALBIZ (6/18/2025, 7:00:00 PM)

3.84

-0.03 (-0.78%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.71%
Inst Owner ChangeN/A
Ins Owners53.65%
Ins Owner ChangeN/A
Market Cap22.54M
Analysts87.27
Price Target8.3 (116.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.58%
PT rev (3m)-17.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-79.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.62
P/S 0.18
P/FCF N/A
P/OCF 41.19
P/B 1.61
P/tB N/A
EV/EBITDA 12.82
EPS(TTM)-0.08
EYN/A
EPS(NY)0.26
Fwd EY6.84%
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)0.09
OCFY2.43%
SpS20.82
BVpS2.39
TBVpS-2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.74%
ROE -2.82%
ROCE 2.72%
ROIC 1.97%
ROICexc 2.3%
ROICexgc 9.31%
OM 0.87%
PM (TTM) N/A
GM 13.29%
FCFM N/A
ROA(3y)-1.38%
ROA(5y)-0.07%
ROE(3y)-2.28%
ROE(5y)3.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-2.32%
ROICexcg growth 5YN/A
ROICexc growth 3Y-13.58%
ROICexc growth 5YN/A
OM growth 3Y-11.82%
OM growth 5YN/A
PM growth 3Y-46.22%
PM growth 5YN/A
GM growth 3Y-13.91%
GM growth 5YN/A
F-Score3
Asset Turnover2.3
Health
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF N/A
Debt/EBITDA 7.61
Cap/Depr 114.93%
Cap/Sales 1.95%
Interest Coverage 250
Cash Conversion 17.44%
Profit Quality N/A
Current Ratio 1.87
Quick Ratio 1.33
Altman-Z 2.96
F-Score3
WACC6.43%
ROIC/WACC0.31
Cap/Depr(3y)67.97%
Cap/Depr(5y)167.31%
Cap/Sales(3y)1.82%
Cap/Sales(5y)5.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-580.5%
EPS 3Y-20.63%
EPS 5YN/A
EPS Q2Q%-3100%
EPS Next Y-78.57%
EPS Next 2Y47.84%
EPS Next 3Y48.88%
EPS Next 5YN/A
Revenue 1Y (TTM)185.23%
Revenue growth 3Y75.48%
Revenue growth 5YN/A
Sales Q2Q%204.93%
Revenue Next Year53.01%
Revenue Next 2Y28.59%
Revenue Next 3Y20.8%
Revenue Next 5Y14.63%
EBIT growth 1Y184.04%
EBIT growth 3Y54.74%
EBIT growth 5YN/A
EBIT Next Year171.35%
EBIT Next 3Y70.07%
EBIT Next 5Y58.29%
FCF growth 1Y-57.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y187.39%
OCF growth 3Y277.76%
OCF growth 5YN/A